Navigation Links
Insmed Incorporated Provides Regulatory Update
Date:10/10/2011

MONMOUTH JUNCTION, N.J., Oct. 10, 2011 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that the Company has been notified by the U.S. Food and Drug Administration (FDA) that it is continuing the clinical hold previously placed on Insmed's phase 3 clinical trials for ARIKACE® (liposomal amikacin for inhalation) in Cystic Fibrosis (CF) patients with Pseudomonas lung infections. Insmed has not yet received a response from FDA regarding the clinical hold previously placed on Insmed's phase 3 clinical trials for ARIKACE in patients with non-tuberculous mycobacterial (NTM) lung disease.  

As announced on August 1, 2011, the clinical holds placed on ARIKACE in CF and NTM were based on an initial review by FDA of the interim results of a long-term rat inhalation carcinogenicity study reported to the agency by Insmed with ARIKACE.  At that time, FDA requested additional information on ARIKACE and data from the rat study.  Insmed submitted its complete response to this request before the end of August.

Insmed has been informed by FDA that, based on its review of the information provided to date, including the rat inhalation carcinogenicity study results, the agency has insufficient information to assess the risks for ARIKACE in CF patients.  FDA has requested additional information from the Company, including that Insmed conduct a dog inhalational 9-month toxicity study of ARIKACE to determine if the findings of the rat inhalation carcinogenicity study are also demonstrated in a non-rodent model, and to propose a CF patient population/disease state where the risk-benefit profile of ARIKACE may be more favorable.

"Insmed is in the process of assessing the impact that FDA's recent requests and the continuation of the clinical hold will have on our phase 3 clinical trials for ARIKACE in CF," said Timothy Whitten, President and CEO of Insmed.  "Once we have a better un
'/>"/>

SOURCE Insmed Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
2. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
3. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
4. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
5. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
6. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
7. Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
8. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
9. Insmed to Host Third Quarter 2010 Conference Call
10. Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2010
11. NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Sorrento Therapeutics, Inc. (OTCBB: SRNE; or STI) ... Business Technology Transfer Research (STTR) grant (#1R42AI098182-02) from ... (NIAID), a division of the National Institutes of ... antibody therapeutics to combat Staphylococcus aureus ... methicillin-resistant S. aureus (MRSA), was renewed ...
(Date:5/17/2013)... 17, 2013   Shareholder rights attorneys  at Robbins ... Inc. (NASDAQGS: AVEO) securities has filed a complaint in ... Massachusetts .  The complaint alleges that Aveo ... Act of 1934 (the "Exchange Act") between January 3, ... (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) ...
(Date:5/17/2013)... YORK , May 17, 2013 /PRNewswire-iReach/ -- United ... Advanced Cardiac Life Support (ACLS), Pediatric Advanced Life Support ... free PALS, BLS and ACLS online course ... manuals, people simply need to build an account with ... materials for these programs, United Medical Education is setting ...
Breaking Medicine Technology:Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2
... Trial Demonstrates Increased Dermal Penetration of TPM/Lidocaine Compared to ... MELBOURNE, Australia, Dec. 8 Phosphagenics Limited ("Phosphagenics") (ASX: ... a phase 1 clinical trial that examined the ability ... deliver the pain relief drug, lidocaine, safely into humans. ...
... SUPG ), a pharmaceutical company dedicated to the discovery ... PIM kinase inhibitor, SGI-1776, is effective both in vitro and in ... . This research was presented at the 50th Annual ... , In a poster presentation entitled " ...
Cached Medicine Technology:Positive Phase 1 Clinical Trial Results for Transdermal Lidocaine 2Positive Phase 1 Clinical Trial Results for Transdermal Lidocaine 3SuperGen's PIM Kinase Inhibitor, SGI-1776, Effective in Pre-Clinical Models of Acute Lymphoblastic Leukemia 2SuperGen's PIM Kinase Inhibitor, SGI-1776, Effective in Pre-Clinical Models of Acute Lymphoblastic Leukemia 3
(Date:5/20/2013)... Along with most every other dentist in the United States, ... regular oral hygiene, encouraging all of his patients to engage ... recommendations are commonplace throughout the world, Melamed notes that current ... are not receiving the message. As such, he explains that ... the practice of flossing to help reinforce dental hygiene. ...
(Date:5/20/2013)... May 20, 2013 Senior Solutions Management ... care across the Southeast, today announced that four of ... assisted living communities have received The Caring Heart ... Place Assisted Living Loudon, Nicole Braden from River Oaks ... in Lenoir City and Meghan McCormick from Wellspring Senior ...
(Date:5/20/2013)... 20, 2013 The main objective for the ... proteomics into a single comprehensive report. The objective was ... in this industry. Thus, it is timely to examine ... also an urgent need in the life science industry for ... proteome in a high-throughput, multiplex and low-cost way. Proteomic ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Idol lash has ... thicker, darker and fuller eyelashes in a matter of few ... for online purchase with an extra pack offer to help ... easily access this offer on the Idol lash official website. ... to increase the eyelash density up to 82% in just ...
(Date:5/20/2013)... The Semi Truck Accident Victims Center says, ... an innocent victim of a catastrophic semi truck, or ... are unparalleled. What this means is if you, or ... passenger vehicle involved in a semi truck accident anywhere ... Jersey, Indiana, Maryland, Georgia, Nebraska, Kansas, Michigan, Colorado, Wyoming, ...
Breaking Medicine News(10 mins):Health News:New AirFloss Product Offers Oral Hygiene Innovation, Dental Professional Warren Melamed Comments 2Health News:Senior Solutions Management Caregivers Receive Caring Heart Award From Alzheimer’s Tennessee 2Health News:Proteomics Market - Mass Spectrometry & Biochips 2017 Forecast & Analysis in New Research Report at ReportsnReports.com 2Health News:Proteomics Market - Mass Spectrometry & Biochips 2017 Forecast & Analysis in New Research Report at ReportsnReports.com 3Health News:Idol Lash Eyelash Growth Enhancer Now Offered Extra Pack for Limited Time Only at HealthCareSupplementz.com 2Health News:Semi Truck Accident Victims Center Urges Family Members Of Victims Injured In A Horrific Semi Truck Accident In Any US State To Call Them First For An Unsurpassed Response 2
... up and take notice in health care apart from AIDS or ... enough to bolster people to sit up and listen. But should ... disease? Or should we use our gray cells and analyse the ... is written about and said about the dreaded disease? Especially so ...
... couples who are HIV sero discordant but who would like to ... the wife is negative and they are planning to have a ... 500 risk of transmitting the virus to the female partner and ... in which infected sperm are washed free of virus before insemination ...
... – the deadly Ebola virus in its latest outbreak has ... Ministry officials in Kampala. More shocking is the fact ... nurses. But what shocked the nation was the death ... the fight against Ebola in Gulu. There is no ...
... publish its findings on the human genome project ... the mapping of the genes will enable one to have ... the eye or even skin. It will also help say ... to screen babies in the womb for diseases, and device ...
... published in the December issue of the Journal ... in peripheral blood mononuclear cells (PBMCs) from individuals ... infected patients treated with antifilarial agents. According ... the National Institute of Allergy and Infectious Diseases ...
... clue if the heart attack patients should get an immediate ... their hearts. , ,Cleveland Clinic cardiologist, Dr. Deepak Bhatt ... and found that patients whose white blood cell count is ... much higher risk of death after a heart attack than ...
Cached Medicine News:Health News:The Cancer Rumour mill working over time 2Health News:Sperm washing helps couples – Breakthrough in focu 2
... Class II Direct to High Res SSP kits provide ... single tray. Locus specific typing on a single tray ... Straight from genomic DNA to high resolution results, ... level typing with a single tray , Unique reaction ...
... Res SSP kits provide high resolution typing of the ... on a single tray reduces QC and testing costs ... to high resolution results, no need for initial low ... tray , Unique reaction pattern for most common alleles ...
... utilizes allele-specific primer combinations in the PCR ... that only primers whose sequence is completely ... converted by the polymerase into PCR products. ... product. Using the Biotest SSP Kit Systems, ...
... freezer is constructed with built-in bags as in ... bags are placed without contacting the ethylene glycol ... inserts. This device ensures easy handling and maximum ... bags so that the relatively hot air under ...
Medicine Products: